Local Delivery of Recombinant Human Bone Morphogenetic Protein-2 Increases Axonal Regeneration and the Expression of Tau Protein after Facial Nerve Injury
Free accessResearch articleFirst published online October, 2010
Local Delivery of Recombinant Human Bone Morphogenetic Protein-2 Increases Axonal Regeneration and the Expression of Tau Protein after Facial Nerve Injury
This study explored the function and possible mechanism of bone morphogenetic protein-2 (BMP-2) in the healing of injured peripheral nerves in vivo. Rabbit facial nerves were injured by clamping and then treated with recombinant human BMP-2 (rhBMP-2) or phosphate-buffered saline (control) by injecting once during surgery and twice a day post-injury for 7 days. Facial nerve fragments within 5 mm of the clamping point were examined at different times post-surgery. Axon structures visualized by Bielschowsky staining were similar in experimental and control nerves 2 and 6 weeks post-injury. At 4 weeks post-injury, cross-section images of facial nerves showed that axons treated with rhBMP-2 were denser and thicker, and levels of tau protein were increased. It is concluded from these data that rhBMP-2 may affect injured facial nerve regeneration by inducing more neurons to return to embryonic patterns of tau gene expression.
ZachariadesNPavassiliouDKonsolakiE: Post-traumatic and postoperative peripheral paralysis of the facial nerve. Ann Dent1993; 52: 9–11.
2.
Sartoretti-ScheferSScherlerMWichmannW: Contrast-enhanced MR of the facial nerve in patients with posttraumatic peripheral facial nerve palsy. AJNR Am J Neuroradiol1997; 18: 1115–1125.
3.
YamaguchiA: Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily. Semin Cell Biol1995; 6: 165–173.
4.
MehlerMFMabiePCZhangD: Bone morphogenetic proteins in the nervous system. Trends Neurosci1997; 20: 309–317.
5.
GossrauGThieleJKonangR: Bone morphogenetic protein-mediated modulation of lineage diversification during neural differentiation of embryonic stem cells. Stem Cells2007; 25: 939–949.
6.
FuMVohraBPWindD: BMP signaling regulates murine enteric nervous system precursor migration, neurite fasciculation, and patterning via altered Ncam1 polysialic acid addition. Dev Biol2006; 299: 137–150.
7.
WaltersBJSaldanhaCJ: Glial aromatization increases the expression of bone morphogenetic protein-2 in the injured zebra finch brain. J Neurochem2008; 106: 216–223.
8.
KinameriEMatsuokaI: Autocrine action of BMP2 regulates expression of GDNF-mRNA in sciatic Schwann cells. Brain Res Mol Brain Res2003; 117: 221–227.
9.
WangYLWangDZNieX: The role of bone morphogenetic protein-2 in in vivo regeneration of peripheral nerves. Br J Oral Maxillofac Surg2007; 45: 197–202.
10.
FawcettWJMathewsGHousdenE: Regeneration sciatic nerve axons contain the adult rather than the embryonic pattern of microtubule associated proteins. Neuroscience1994; 61: 789–804.
11.
ChambersCBMumaNA: Tau mRNA isoforms following sciatic nerve axotomy with and without regeneration. Brain Res Mol Brain Res1997; 48: 115–124.
12.
ZhangYDaRRHilgenbergLG: Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. J Neuroimmunol2005; 167: 120–130.
13.
UchiharaTDuyckaertsCSeilheanD: Exclusive induction of tau2 epitope in microglia/macrophages in inflammatory lesions–tautwopathy distinct from degenerative tauopathies. Acta Neuropathol2005; 109: 159–164.
14.
UchiharaTNakamuraANakayamaH: Triple immunofluorolabeling with two rabbit polyclonal antibodies and a mouse monoclonal antibody allowing three-dimensional analysis of cotton wool plaques in Alzheimer disease. J Histochem Cytochem2003; 51: 1201–1206.
15.
IwasakiSHattoriASatoM: Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. Induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation. J Biol Chem1996; 271: 17360–17365.
16.
IwasakiSIguchiMWatanabeK: Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J Biol Chem1999; 274: 26503–26510.
17.
HattorlATsujimotoMHayashiK: Bone morphogenetic protein-2 is markedly synergistic with tumor necrosis factor in stimulating the production of nerve growth factor in fibroblasts. Biochem Mol Biol Int1996; 38: 1095–1100.
18.
LiHGrumetM: BMP and LIF signaling coordinately regulate lineage restriction of radial glia in the developing forebrain. Glia2007; 55: 24–35.
19.
MumaNAHoffmanPNSluntHH: Alterations in levels of mRNAs coding for neurofilament protein subunits during regeneration. Exp Neurol1990; 107: 230–235.
20.
ChambraudBSardinEGiustinianiJ: A role for FKBP52 in Tau protein function. Proc Natl Acad Sci USA2010; 107: 2658–2663.
21.
NothiasFBoyneLMurrayM: The expression and distribution of tau proteins and messenger RNA in rat dorsal root ganglion neurons during development and regeneration. Neuroscience1995; 66: 707–719.
22.
Gordon-KrajcerWKozniewskaELazarewiczJW: Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils. Neurochem Res2007; 32: 729–737.
23.
GorlovoyPLarionovSPhamTT: Accumulation of tau induced in neurites by microglial proinflammatory mediators. FASEB J2009; 23: 2502–2513.
24.
BelkadiALoPrestiP: Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line. J Neurochem2008; 107: 351–360.
25.
YinHSChouHCChiuMM: Changes in the microtubule proteins in the developing and transected spinal cords of the bullfrog tadpole: Induction of microtubule-associated protein 2c and enhanced levels of tau and tubulin in regeneration central axons. Neuroscience1995; 67: 763–775.
